Search Result "atherogenic lipoproteins"

Atherogenic Versus Non-atherogenic Lipoprotein Profiles in Healthy Individuals. Is There a Need to Change Our Approach to Diagnosing Dyslipidemia?

Journal: Current Medicinal Chemistry
Volume: 21 Issue: 25 Year: 2014 Page: 2892-2901
Author(s): S. Oravec,A. Dukat,P. Gavornik,M. Kucera,K. Gruber,L. Gaspar,M. Rizzo,P.P. Toth,D.P. Mikhailidis,M. Banach

Review Article

PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 6 Year: 2017 Page: 894-902
Author(s): Dragana Nikolic,Giuseppa Castellino,Maciej Banach,Peter P. Toth,Ekaterina Ivanova,Alexander N. Orekhov,Giuseppe Montalto,Manfredi Rizzo

Cross-talk Between Exogenous Statins and Endogenous High-Density Lipoprotein in Anti-Inflammatory and Anti-Atherogenic Actions

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 10 Issue: 1 Year: 2010 Page: 8-15
Author(s): Takao Kimura, Koichi Sato, Hideaki Tomura, Fumikazu Okajima

Lipoprotein Lipase and Atherosclerosis

Journal: Current Vascular Pharmacology
Volume: 1 Issue: 1 Year: 2003 Page: 11-17
Author(s): K. Tsutsumi

Review Article

Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of Patients' Blood: Development of Therapeutic Approaches to Reduce Blood Atherogenicity

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 6 Year: 2017 Page: 932-936
Author(s): Nikita G. Nikifirov,Emile R. Zakiev,Natalia V. Elizova,Vasily N. Sukhorukov,Alexander N. Orekhov

Review Article

Lipoprotein Apheresis and PCSK9-Inhibitors. Impact on Atherogenic Lipoproteins and Anti-Inflammatory Mediators in Familial Hypercholesterolaemia

Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3634-3637
Author(s): Claudia Stefanutti,Maria Grazia Zenti

“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos

Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5954-5962
Author(s): Igor A. Sobenin, Dimitry A. Chistiakov, Yuri V. Bobryshev, Anton Y. Postnov, Alexander N. Orekhov

Review Article

Metabolic Syndrome, Dyslipidemia and Regulation of Lipoprotein Metabolism

Journal: Current Diabetes Reviews
Volume: 14 Issue: 5 Year: 2018 Page: 427-433
Author(s): Jahangir Iqbal,Ali Al Qarni,Abbas Hawwari,Ahmad F. Alghanem,Gasmelseed Ahmed

Platelet Signaling Induced by Lipoproteins

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4 Issue: 2 Year: 2006 Page: 93-109
Author(s): S. J.A. Korporaal, J. W.N. Akkerman

Previous   Next

Go To   Results 1 - 1 of 1661

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2024 Bentham Science Publishers | Privacy Policy